secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kiromic Biopharma, Inc. (—)
CIK:        0001792581
Form:       8-K
Filed at:   2023-03-10T23:59:59+00:00
Accession:  0001104659-23-031201
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiromic BioPharma effects 1-for-30 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse split at 1-for-30 effective March 10, 2023 at 4:01 pm ET; trading on split-adjusted basis March 13.
- Post-split shares outstanding approximately 966,758; fractional shares rounded up to whole share.
- Trading symbol KRBP unchanged; new CUSIP number 497634204.
- Split approved by stockholders on March 7, 2023; board set ratio at 1-for-30.
- Primary purpose: meet Nasdaq minimum bid price requirement for continued listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/0001104659-23-031201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1792581/000110465923031201/tm239172d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-031201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer